State of Alaska Department of Revenue’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
21,565
-770
| -3% | -$42.3K | 0.01% | 961 |
|
|
2025
Q1 | $1.58M | Buy |
22,335
+605
| +3% | +$42.7K | 0.02% | 791 |
|
|
2024
Q4 | $1.43M | Sell |
21,730
-7,495
| -26% | -$493K | 0.02% | 871 |
|
|
2024
Q3 | $2.05M | Sell |
29,225
-7,045
| -19% | -$495K | 0.02% | 704 |
|
|
2024
Q2 | $2.99M | Buy |
36,270
+15,175
| +72% | +$1.25M | 0.03% | 536 |
|
|
2024
Q1 | $1.84M | Sell |
21,095
-6,870
| -25% | -$600K | 0.02% | 729 |
|
|
2023
Q4 | $2.7M | Buy |
27,965
+360
| +1% | +$34.7K | 0.03% | 566 |
|
|
2023
Q3 | $2.44M | Buy |
27,605
+865
| +3% | +$76.5K | 0.03% | 565 |
|
|
2023
Q2 | $2.32M | Buy |
26,740
+22,505
| +531% | +$1.95M | 0.03% | 608 |
|
|
2023
Q1 | $411K | Hold |
4,235
| – | – | ﹤0.01% | 1450 |
|
|
2022
Q4 | $438K | Sell |
4,235
-250
| -6% | -$25.9K | 0.01% | 1402 |
|
|
2022
Q3 | $380K | Sell |
4,485
-670
| -13% | -$56.8K | 0.01% | 1438 |
|
|
2022
Q2 | $427K | Buy |
+5,155
| New | +$427K | 0.01% | 1416 |
|
|
2020
Q3 | – | Sell |
-86,641
| Closed | -$10.7M | – | 1639 |
|
|
2020
Q2 | $10.7M | Buy |
+86,641
| New | +$10.7M | 0.14% | 183 |
|
|
2019
Q3 | – | Sell |
-20,677
| Closed | -$1.77M | – | 1649 |
|
|
2019
Q2 | $1.77M | Buy |
20,677
+77
| +0.4% | +$6.59K | 0.03% | 559 |
|
|
2019
Q1 | $1.83M | Sell |
20,600
-1,207
| -6% | -$107K | 0.03% | 544 |
|
|
2018
Q4 | $1.86M | Buy |
21,807
+175
| +0.8% | +$14.9K | 0.04% | 514 |
|
|
2018
Q3 | $2.1M | Buy |
21,632
+342
| +2% | +$33.2K | 0.04% | 524 |
|
|
2018
Q2 | $2.01M | Sell |
21,290
-541
| -2% | -$50.9K | 0.04% | 531 |
|
|
2018
Q1 | $1.77M | Buy |
21,831
+3,140
| +17% | +$254K | 0.04% | 541 |
|
|
2017
Q4 | $1.67M | Buy |
18,691
+13,080
| +233% | +$1.17M | 0.04% | 528 |
|
|
2017
Q3 | $522K | Buy |
5,611
+1,860
| +50% | +$173K | 0.03% | 682 |
|
|
2017
Q2 | $340K | Buy |
3,751
+350
| +10% | +$31.7K | 0.02% | 584 |
|
|
2017
Q1 | $298K | Buy |
+3,401
| New | +$298K | 0.02% | 498 |
|